PCPE-1 promotes cardiac fibrosis with aging and obesity
JCI Insight · 2026
DOI: 10.1172/jci.insight.195508 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Yung-Ting Hsiao und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Aging, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan. Hauptthemen laut MEDLINE: Obesity, Aging, Myocardium, Heart Failure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JST FOREST Program, JSPS, AMED.
Abstract (Originalsprache)
Heart failure with preserved ejection fraction (HFpEF) is a multifactorial disease that develops in several clinical settings. Despite its complex pathogenesis, evidence indicates a central role for fibrosis in the progression of left ventricular diastolic dysfunction (LVDD). Through exploratory research into adipokines derived from brown adipose tissue (BAT), we identified a secreted-type profibrotic protein, procollagen C-endopeptidase enhancer-1 (PCPE-1), whose expression increased in BAT with aging. PCPE-1 promotes the cleavage of procollagens and is a critical initiator of fibrillogenesis. This molecule was increased in the plasma of aged mice. In addition to aging, obesity led to an increase in PCPE-1 expression in the LV of mice. Both systemic and BAT-specific PCPE-1 depletion ameliorated LV fibrosis and LVDD in the obese HFpEF model. Our data also showed that age-associated LVDD was ameliorated in the systemic PCPE-1–KO mouse fed with a normal chow diet. Conversely, the overexpression of PCPE-1 expression in BAT was shown to lead to aggravation of LV fibrosis and LVDD. Mechanistically, we found ROS/DNA damage/c-Fos/c-Jun signaling resulted in an increased production of PCPE-1 in brown adipocytes. These results indicate PCPE-1 may represent a druggable target for aging- and obesity-related HFpEF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Aging, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
- Department of Cardiovascular Biology and Medicine, and.
- Department of Advanced Senotherapeutics, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- Department of Cardiac Physiology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
- Department of Cardiovascular Pathophysiology and Therapeutics, The University of Osaka Graduate School of Medicine, Osaka, Japan.
- Division of Bioinformatics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Förderung
- JST FOREST Program
- JSPS
- AMED
Zitieren
APA
Hsiao, Y. T., Yoshida, Y., Tsuchimochi, H., Tang, J., Aung, T. M., Chang, C. H., Barinda, A. J., Li, Z., Othman, N. S. B., Yoshizaki, T., Ling, Y., Okuda, S., Abe, M., Mizuno, S., Takahashi, S., Inomata, T., Kioka, H., Sakata, Y., Maeda, D., …, & Shimizu, I. (2026). PCPE-1 promotes cardiac fibrosis with aging and obesity. JCI Insight. https://doi.org/10.1172/jci.insight.195508
Vancouver
Hsiao YT, Yoshida Y, Tsuchimochi H, Tang J, Aung TM, Chang CH, et al. PCPE-1 promotes cardiac fibrosis with aging and obesity. JCI Insight. 2026. doi:10.1172/jci.insight.195508
BibTeX
@article{Hsiao2026,
author = {Hsiao, Yung-Ting and Yoshida, Yohko and Tsuchimochi, Hirotsugu and Tang, Jingyuan and Aung, Tin May and Chang, Chun-Han and Barinda, Agian Jeffilano and Li, Zhihong and Othman, Nur Syakirah Binti and Yoshizaki, Tom and Ling, Yiwei and Okuda, Shujiro and Abe, Manabu and Mizuno, Seiya and Takahashi, Satoru and Inomata, Takayuki and Kioka, Hidetaka and Sakata, Yasushi and Maeda, Daichi and Matsue, Yuya and Furihata, Takaaki and Iwata, Hiroshi and Pearson, James T and Otsu, Kinya and Walsh, Kenneth and Ishigami, Akihito and Minamino, Tohru and Shimizu, Ippei},
title = {PCPE-1 promotes cardiac fibrosis with aging and obesity},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.195508}
}
EUVIMED